Featured
Featured
Featured
Featured
Featured
menu
search
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus
NIH staff guidance on coronavirus (NIH Only)
You are here
Press Releases
Press Releases
RSS 
CSV
XLSX
NIH study supports new approach for treating cerebral malaria
Tuesday, February 18, 2020
Researchers at the National Institutes of Health found evidence that specific immune cells may play a key role in the devastating effects of cerebral malaria, a severe form of malaria that mainly affects young children.
Dr. John Ngai named director of NIH BRAIN Initiative
Wednesday, January 29, 2020
National Institutes of Health Director Francis S. Collins, M.D., Ph.D., announced today the selection of John J. Ngai, Ph.D., as director of the NIH’s Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative. Dr. Ngai is expected to join NIH in March.
Study finds differences in energy use by immune cells in ME/CFS
Thursday, December 12, 2019
New findings published in the Journal of Clinical Investigation suggest that specific immune T cells from people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) show disruptions in the way they produce energy.
Head-to-head comparison finds three anti-seizure drugs equally effective for severe form of epilepsy
Wednesday, November 27, 2019
There are three treatment options commonly used by doctors in the emergency room to treat patients with refractory status epilepticus, severe seizures that continue even after benzodiazepine medications, which are effective in controlling seizures in more than two-thirds of patients.
Accelerating Medicines Partnership launches data knowledge portal for Parkinson’s disease
Friday, November 22, 2019
The Accelerating Medicines Partnership (AMP) program for Parkinson’s disease (PD) has launched a data portal to provide de-identified information collected from 4,298 PD patients and healthy controls to researchers working to develop effective therapies for the disease.
NIH Awards Funding for Early Autism Screening
Wednesday, November 6, 2019
The National Institutes of Health (NIH) has awarded more than four million dollars in FY 2019 to support seven research projects aimed at developing and validating screening tools to detect signs of autism spectrum disorder in the first year of life.
Pathogenic tau and cognitive impairment are precipitated by a high-salt diet
Wednesday, October 23, 2019
High levels of dietary salt can activate a pathway in the brain to cause cognitive impairment, according to a new study.
New NIH BRAIN Initiative awards accelerate neuroscience discoveries
Friday, October 18, 2019
Scientists have been developing astounding new tools for exploring neural circuits that underlie brain function throughout the first five years of the National Institutes of Health’s Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative. Now, the NIH has announced its...
NIH pairs cutting-edge neuroethics with ground-breaking neurotechnologies
Thursday, October 17, 2019
With support from the National Institutes of Health’s Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative, scientists are developing powerful new devices and technologies to monitor and regulate brain activity.
